Climb Bio, Inc. SEC filings CLYM
Climb Bio, Inc. has 325 filings in SEC EDGAR's recent list, going back to Feb 19, 2019. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 26, 2026 | Oct 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 23, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 3, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Other events
|
Aug 14, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 1, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 12, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Other events
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 8, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Other events
|
Jun 5, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 5, 2026 | May 5, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 28, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2026 | Apr 1, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Other events
|
Dec 31, 2025 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 11, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Other events
|
Oct 17, 2025 | Oct 17, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 1, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 29, 2025 | Sep 29, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 18, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Officer or director change
|
May 23, 2025 | May 23, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Material agreement, Results of operations
|
Mar 25, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Jan 10, 2025 | Jan 8, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 15, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 2, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2024 | Aug 23, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 26, 2024 | Aug 26, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
|
Jun 27, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 26, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 12, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Apr 11, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Other events
|
Mar 19, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 20, 2023 | Jul 20, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2023 | May 18, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 16, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change, Other events
|
Feb 14, 2023 | Feb 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 24, 2023 | Jan 19, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 20, 2022 | Dec 14, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Oct 5, 2022 | Oct 5, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Other events
|
Jul 18, 2022 | Jul 18, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 24, 2022 | May 19, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Other events
|
Apr 25, 2022 | Apr 25, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 29, 2022 | Mar 28, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 7, 2022 | Mar 7, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 31, 2022 | Jan 27, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 18, 2022 | Jan 18, 2022 |
| 8-K |
Current report
Other events
|
Nov 22, 2021 | Nov 22, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2021 | Nov 8, 2021 |
| 8-K/A |
Amended current report
Results of operations
|
Sep 14, 2021 | Sep 13, 2021 |
| 8-K |
Current report
Results of operations
|
Sep 13, 2021 | Sep 13, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 12, 2021 | Aug 12, 2021 |
Showing 66 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CLYM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wellesley Hills, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1768446
- Former names
- Eliem Therapeutics, Inc. (until Sep 20, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.